Long-term vemurafenib therapy in advanced melanoma patients: cutaneous toxicity and prognostic implications.

The introduction of targeted therapies for the treatment of BRAF-mutated metastatic melanoma was associated with different cutaneous adverse events (AEs). To describe the type, frequency and severi...